Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Publication stageIn Press Accepted Manuscript
Precis: Increases in drug prices and drug spending are of concern to health systems worldwide. This has naturally driven policy interest and discussion around drug pricing and the need to balance affordability with sustaining innovation.
Concept and design: Mauskopf
Analysis and interpretation of Data: Mauskopf
Drafting of the manuscript: Mauskopf, Khalid
Critical Revision of Paper for important intellectual content: Mauskopf, Khalid
Administrative, technical, or logistic support: Khalid
Conflict of Interest Disclosure Statement:
Dr Kamal reported receiving grants from Cerevel Therapeutics, EMD Serono, and other from Pharmacy Times and Continuing Education outside the submitted work. Dr Mauskopf works on research studies contracted between her employer, RTI Health Solutions, and pharmaceutical company sponsors. As a salaried employee, her compensation is not connected to the projects she works on. No other disclosures were reported.